This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

Clinical

5-alpha reductase inhibitor use not linked to prostate cancer mortality
5-alpha reductase inhibitor use not linked to prostate cancer mortality
Read more
High seafood intake reduces 10-year risk of CVD-related mortality
High seafood intake reduces 10-year risk of CVD-related mortality
Read more
My healthcare journey: from appendicitis to Hospital Healthcare Europe
My healthcare journey: from appendicitis to Hospital Healthcare Europe
Read more
Both forms of cardiovascular disease associated with higher cancer risk
Both forms of cardiovascular disease associated with higher cancer risk
Read more
Different beverages affect all-cause mortality in type 2 diabetes
Different beverages affect all-cause mortality in type 2 diabetes
Read more
RCT finds tralokinumab effective in adolescents with atopic eczema
RCT finds tralokinumab effective in adolescents with atopic eczema
Read more
Successful psychological therapy for depression may reduce subsequent CVD risk
Successful psychological therapy for depression may reduce subsequent CVD risk
Read more
Pembrolizumab explored in the treatment of advanced biliary tract cancer
Pembrolizumab explored in the treatment of advanced biliary tract cancer
Read more
Adding ipilimumab to nivolumab of little value in recurrent or metastatic head & neck SCC
Adding ipilimumab to nivolumab of little value in recurrent or metastatic head & neck SCC
Read more
Psilocybin therapy effective for major depression among cancer patients
Psilocybin therapy effective for major depression among cancer patients
Read more
ChatGPT shows promise but only for low-complex cardiology questions
ChatGPT shows promise but only for low-complex cardiology questions
Read more
GD2-CART01 effective for R/R high-risk neuroblastoma 
GD2-CART01 effective for R/R high-risk neuroblastoma 
Read more
Moderate dietary salt restriction reduces BP in primary aldosteronism
Moderate dietary salt restriction reduces BP in primary aldosteronism
Read more
Endocan useful marker for disease extent in ulcerative colitis
Endocan useful marker for disease extent in ulcerative colitis
Read more
Reduced human beta-defensin-2 levels associated with COPD exacerbations
Reduced human beta-defensin-2 levels associated with COPD exacerbations
Read more

Popular articles

Exacerbations reduced by dupilumab in COPD patients with type 2 inflammation
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
Government commits to easing pressure on NHS through commercial clinical trial investment





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora